China Shineway Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG2110P1000
HKD
9.76
0.29 (3.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
4,096.24
4,990.77
4,594.11
3,885.06
2,984.19
3,068.37
3,044.28
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,096.24
4,990.77
4,594.11
3,885.06
2,984.19
3,068.37
3,044.28
Raw Material Cost
1,025.99
1,240.27
1,177.21
980.09
750.46
821.44
822.19
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
258.24
320.92
335.43
311.00
242.01
263.44
218.53
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.65
3.02
0.73
1.51
18.65
3.01
0.00
Selling and Distribution Expenses
2,054.86
2,556.48
2,450.51
2,125.10
1,647.05
1,594.74
1,482.84
Other Expenses
-15.59
-20.19
-19.96
-17.67
-14.86
-15.00
-6.68
Total Expenditure (Excl Depreciation)
3,189.84
3,918.81
3,764.31
3,241.04
2,509.55
2,532.65
2,456.79
Operating Profit (PBDIT) excl Other Income
906.4
1072
829.8000000000001
644
474.6
535.7
587.5
Other Income
342.46
301.55
237.24
225.36
245.54
242.20
205.06
Operating Profit (PBDIT)
1,323.39
1,440.06
1,135.29
946.11
775.42
838.42
840.97
Interest
6.65
3.02
0.73
1.51
18.65
3.01
0.00
Exceptional Items
0.00
0.00
0.08
0.00
-257.64
-46.06
0.00
Gross Profit (PBDT)
3,070.25
3,750.49
3,416.90
2,904.96
2,233.73
2,246.93
2,222.09
Depreciation
74.52
66.56
68.24
76.72
55.24
60.49
48.41
Profit Before Tax
1,242.22
1,370.48
1,066.39
867.88
443.89
728.85
792.55
Tax
331.41
299.17
225.89
196.97
112.36
158.32
193.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
910.80
1,071.31
840.50
670.91
331.53
570.53
599.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
910.80
1,071.31
840.50
670.91
331.53
570.53
599.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
910.80
1,071.31
840.50
670.91
331.53
570.53
599.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.11
Reserves
7,946.37
7,745.32
7,165.92
7,219.08
6,869.82
6,462.04
6,575.05
Earnings per share (EPS)
1.21
1.42
1.11
0.89
0.44
0.73
0.73
Diluted Earnings per share
1.21
1.42
1.11
0.89
0.44
0.73
0.73
Operating Profit Margin (Excl OI)
22.13%
21.48%
18.06%
16.58%
15.91%
17.46%
19.3%
Gross Profit Margin
32.15%
28.79%
24.7%
24.31%
16.73%
25.73%
27.62%
PAT Margin
22.24%
21.47%
18.3%
17.27%
11.11%
18.59%
19.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -17.92% vs 8.63% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -14.98% vs 27.46% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -13.84% vs 26.78% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 120.00% vs 328.57% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of China Shineway Pharmaceutical Group Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
4,096.24
5,522.67
-1,426.43
-25.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,096.24
5,522.67
-1,426.43
-25.83%
Raw Material Cost
1,025.99
4,577.23
-3,551.24
-77.58%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
258.24
1,237.60
-979.36
-79.13%
Power Cost
0
0
0.00
Manufacturing Expenses
6.65
337.18
-330.53
-98.03%
Selling and Distribution Expenses
2,054.86
624.38
1,430.48
229.10%
Other Expenses
-15.59
-132.07
116.48
88.20%
Total Expenditure (Excl Depreciation)
3,189.84
5,455.69
-2,265.85
-41.53%
Operating Profit (PBDIT) excl Other Income
906.40
66.98
839.42
1,253.24%
Other Income
342.46
310.09
32.37
10.44%
Operating Profit (PBDIT)
1,323.39
468.78
854.61
182.31%
Interest
6.65
337.18
-330.53
-98.03%
Exceptional Items
0.00
-131.51
131.51
100.00%
Gross Profit (PBDT)
3,070.25
945.44
2,124.81
224.74%
Depreciation
74.52
91.71
-17.19
-18.74%
Profit Before Tax
1,242.22
-91.63
1,333.85
1,455.69%
Tax
331.41
35.07
296.34
845.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
910.80
-126.55
1,037.35
819.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
910.80
-126.55
1,037.35
819.72%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
910.80
-126.55
1,037.35
819.72%
Equity Capital
0
0
0.00
Face Value
0.00
0.10
0.00
Reserves
7,946.37
3,511.55
4,434.82
126.29%
Earnings per share (EPS)
1.21
-0.01
1.22
12,200.00%
Diluted Earnings per share
1.21
-0.01
1.22
12,200.00%
Operating Profit Margin (Excl OI)
22.13%
1.21%
0.00
20.92%
Gross Profit Margin
32.15%
0.00%
0.00
32.15%
PAT Margin
22.24%
-2.29%
0.00
24.53%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 409.62 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -17.92% vs 8.63% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 91.08 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -14.98% vs 27.46% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 98.09 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -13.84% vs 26.78% in Dec 2023

Annual - Interest
Interest 0.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 120.00% vs 328.57% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.13%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023